Skip to content

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS): A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06761170
Acronym
Cryo-BAS
Enrollment
50
Registered
2025-01-07
Start date
2025-06-02
Completion date
2027-01-15
Last updated
2025-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stenosis of Trachea

Keywords

Stenosis of trachea, benign, spray cryotherapy

Brief summary

The goal of this clinical trial is to compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis. The main question\[s\] investigators aim to answer are: 1. What is the need for reintervention and time to reintervention in participants with benign airway stenosis with simple stenosis who receive spray cryotherapy plus balloon dilatation versus standard of care alone? 2. To evaluate patient experience, physiological, anatomical changes, health care utilization and safety of the SCT plus balloon dilatation versus standard of care alone. Researchers will compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis to see if it reduces the need of re intervention. Participants will surgery and receive one of the two interventions.

Detailed description

Investigators propose a single center, single-blinded (patient), randomized 1:1 trial comparing SCT plus Balloon dilatation (experimental group) vs SoC alone (control group). Investigators aim to recruit 50 patients. Study will span 2-year duration with 1 year recruitment. Follow up at 6 weeks, 3 months, 6 months, 12 months. The patient's airway will be either a laryngeal mask airway or a rigid bronchoscopy for passive venting and gas egress.

Interventions

PROCEDURESpray cryo therapy

normal flow, 5 seconds repeated for 3-5 cycles

PROCEDUREStandard of Care (SOC)

1. Steroid injection 2. Radial mucosal incision 3. Balloon dilation (to normal airway diameter)

Sponsors

American Association of Broncology and Interventional Pulmonology
CollaboratorUNKNOWN
Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 1\. Patients with symptomatic, benign, simple stenosis of the trachea and/or subglottic space. * 2\. Stenotic airway of diameter \< 1cm.

Exclusion criteria

1. Complex stenosis, cartilage involvement (malacia or fracture). 2. Patients with giant bullae (\> a third of hemithorax) or bullae \>3cm. 3. Concurrent tracheoesophageal fistula, active tracheal malignancy. 4. Presence of concomitant upper airway obstruction. 5. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Need of re interventionNeed of re intervention in two yearsNumber of patients that require new intervention for the benign airway stenosis.

Secondary

MeasureTime frameDescription
Time to re interventionTwo yearsTime it takes in days for a patient to need a re intervention for the benign airway stenosis after treatment.

Countries

United States

Contacts

Primary ContactChristine Conley
Cconley@bidmc.harvard.edu617-632-8386

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026